JNM Podcast
Podcast of The Journal of Nuclear Medicine (JNM)—a leading medical imaging journal self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). In JNM Podcast, our esteemed editors speak with experts in the field to discuss emerging technologies and rapidly changing issues in practice and research.
JNM: https://jnm.snmjournals.org
SNMMI: http://www.snmmi.org
JNM Podcast
Understanding Metabolic PET Markers Beyond SUV
Standardized uptake values (SUV) measure a patient's response to nuclear medicine therapy. But what other markers of success are there, and do these markers and the interpretation of them vary depending on the disease being imaged? Sally Barrington, MD, works specifically on lymphoma and shares her expertise on what markers of success and criteria are critical to her in understanding patients' responses to treatment. Joining her, along with our host Ken Herrmann, MD, are Louise Emmett, MD, and Irene Buvat, PhD. The panel also discusses the role of AI tools in analyzing risk and response assessment in lymphoma. Tune in now!
Below are resources provided by Dr. Barrington:
Tool to measure the international metabolic prognostic index 'IMPI':https://petralymphoma.org/impi/
Benchmark dataset for MTV measurement: https://zenodo.org/records/11409717
For more JNM articles on this topic, see below:
Methodology for MTV described in DOI: https://jnm.snmjournals.org/content/early/2020/07/16/jnumed.119.238923
Is 18F-FDG Metabolic Tumor Volume in Lymphoma Really Happening? https://doi.org/10.2967/jnumed.123.267022
Deep learning enables TMTV estimation https://doi.org/10.2967/jnumed.120.242412